Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
The Pharmaceutical Market: Romania

Romania pharmaceutical market: Latest market research analysed


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-03-10 23:16:04 - The Pharmaceutical Market: Romania - a new market research report on companiesandmarkets.com

While it is clear that drugmakers operating in Romania are far from happy with the latest revisions to the pharmaceutical claw-back tax, andthe tax remains unfairly punitive, all things considered, the August 2012 amendmentsarea small improvement, thoughdefinitelynot what producers would have wanted ideally. With part of the objective of the claw-back tax to improve the timeliness of payments for reimbursed medicines, which has been a major difficulty for drug producers and distributors over the last four years, there are some upsides to this mechanism working effectively.The tax remains most punitive for generic drugmakers with lower-value medicines and could lead to these cheaper medicines exiting the market. The tax continues to weigh on BMI´s assessment of Romania´s Pharmaceutical and Healthcare Risk/Reward

 

 

ratings.

Headline Expenditure Projections:

Pharmaceuticals: RON12.76bn (US$4.18bn) in 2011 to RON13.52bn (US$3.78bn) in 2012; +6.0% in local currency terms and -9.7% in US dollar terms. Local currency forecast slightly down from Q4 12 on account of macroeconomic factors; US dollar forecast further impacted by exchange rate factors.

Healthcare: RON30.17bn (US$9.90bn) in 2011 to RON32.07bn (US$9.86bn) in 2012; +6.3% in local currency terms and -9.5% in US dollar terms. Local currency forecast slightly down from Q4 12 on account of macroeconomic factors; US dollar forecast further impacted by exchange rate factors.

Medical devices: RON1.61bn (US$527mn) in 2011 to RON1.69bn (US$471mn) in 2012; +5.0% in local currency terms and -10.6% in US dollar terms. Local currency forecast slightly down from Q4 12 on account of macroeconomic factors; US dollar forecast further impacted by exchange rate factors.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com